Evolution of systemic treatment for hormone-sensitive breast cancer: from sequential use of single agents to the upfront administration of drug combinations by E. N. Imyanitov

Connect to this object online.

CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB - A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER by E. N. Imyanitov, T. Yu. Semiglazova

Connect to this object online.

Tumor immune microenvironment and apoptotic markers in breast cancer patients carrying <I>BRCA1</I> gene mutations by A. I. Stukan, A. Yu. Goryainova, O. Yu. Chukhray, S. D. Maksimenko, E. N. Imyanitov, S. V. Sharov, Z. K. Khachmamuk

Connect to this object online.

Clinical and prognostic characteristics of <I>BRCA1/2</I>-associated breast cancer depending on the type of mutation: estrogen signaling pathway and secondary tumors by A. I. Stukan, A. Yu. Goryainova, R. A. Murashko, Z. K. Khachmamuk, O. Yu. Chukhray, S. D. Maksimenko, O. A. Goncharova, E. N. Imyanitov, V. A. Porkhanov

Connect to this object online.

Predictive and prognostic features of early and locally advanced <i>PIK3CA</i>-mutated luminal HER2-negative breast cancer by A. I. Stukan, T. Yu. Semiglazova, S. I. Kutukova, V. A. Porkhanov, V. N. Bodnya, E. N. Imyanitov, V. V. Antipova, Z. K. Khachmamuk, O. Yu. Chukhray, S. D. Maksimenko

Connect to this object online.

Assessment of resection margins during breast-conserving surgery using multimodal optical coherence tomography by D. A. Vorontsov, E. V. Gubarkova, M. A. Sirotkina, A. A. Sovetskiy, S. N. Aleksakhina, T. T. Tabagua, E. A. Busko, E. N. Imyanitov, S. S. Kuznetsov, A. Yu. Vorontsov, E. V. Zagaynova, S. V. Gamayunov, V. Yu. Zaytsev, P. V. Krivorotko, N. D. Gladkova

Connect to this object online.

The role of platinum-based antineoplastic drugs and their impact on complete pathological response and prognosis in patients with BRCA-associated triple-negative breast cancer afte... by D. A. Enaldieva, P. V. Krivorotko, E. N. Imyanitov, E. K. Zhiltsova, R. V. Donskikh, A. P. Sokolenko, L. F. Shaykhelislamova, T. T. Tabagua, L. P. Gigolaeva, A. V. Komyakhov, K. S. Nikolaev, K. Yu. Zernov, S. S. Ereshchenko, R. M. Paltuev, A. A. Bessonov, A. S. Artemyeva, R. S. Pesotskiy, N. S. Amirov, A. S. Emelyanov, V. V. Mortada, Ya. I. Bondarchuk, V. V. Semiglazov, T. Yu. Semiglazova, V. F. Semiglazov, A. M. Belyaev

Connect to this object online.

Predictive multigenic scale. Analysis of own results in metastatic breast cancer by R. M. Paltuev, S. N. Aleksakhina, A. S. Artemyeva, E. A. Baychorov, S. Yu. Bakharev, A. A. Bozhok, V. A. Vasin, V. I. Vladimirov, O. A. Volynshchikova, A. Yu. Vorontsov, E. A. Gaysina, A. A. Hoffman, E. N. Imyanitov, V. V. Klimenko, A. V. Komyakhov, M. M. Konstantinovа, M. V. Kopp, A. G. Kudaybergenova, I. A. Lalak, D. L. Matevosyan, N. M. Mudzhiri, O. V. Poltareva, O. I. Sevryukova, V. F. Semiglazov, T. Yu. Semiglazova, M. M. Urezkova, L. A. Churilova

Connect to this object online.

Assessment of <i>ERBB2</i> and HER2 expression in metastatic breast cancer using the nCounter® system and a 100-gene scale by R.  M.  Paltuev, O.  A.  Volynshchikova, Sh.  R.  Abdullaeva, S.  N.  Aleksakhina, A.  S.  Artemyeva, E.  A.  Baychorov, S.  Yu.  Bakharev, Yu.  A.  Belaya, A.  A.  Bozhok, V.  A.  Vasin, V.  I.  Vladimirov, A.  Yu.  Vorontsov, E.  A.  Gaysina, A.  A.  Gofman, V.  N.  Dmitriev, E.  N.  Imyanitov, V.  V.  Klimenko, A.  V.  Komyakhov, M.  M.  Konstantinova, M. V.  Kopp, A.  G.  Kudaybergenova, I.  A.  Lalak, D.  L.  Matevosyan, N.  M.  Mudzhiri, O.  V.  Poltareva, O.  I.  Sevryukova, V.  F.  Semiglazov, T.  Yu.  Semiglazova, M.  M.  Urezkova, A.  S.  Chichkanova, L.  A.  Churilova, M.  V.  Shomova

Connect to this object online.